Alpha-methyl-acetoacetyl-CoA thiolase deficiency is a rare, inherited metabolic disorder. It is also called beta-ketothiolase (BKT) deficiency or ACAT1 deficiency. In this condition, a mitochondrial enzyme called acetoacetyl-CoA thiolase (also known as T2, encoded by the ACAT1 gene) does not work well. That enzyme helps the body break down the amino acid isoleucine and also helps the body use ketone bodies for energy. When the enzyme is missing or weak, certain acids build up in the blood and urine. During stress, fasting, or illness, children (and sometimes adults) can develop ketoacidosis—a dangerous buildup of acids that can cause vomiting, dehydration, heavy breathing, sleepiness, seizures, or even coma if not treated fast. With early diagnosis and good day-to-day care, most people do well. Orpha+2rarediseases.info.nih.gov+2

Alpha-methyl-acetoacetyl-CoA thiolase deficiency is a rare genetic condition that affects how the body breaks down the amino acid isoleucine and how it uses ketone bodies for energy. The problem comes from harmful changes in the ACAT1 gene. This gene normally makes an enzyme in the cell’s “power plants” (mitochondria) that helps convert certain small fuel molecules into usable energy. When the enzyme does not work well, acids and other breakdown products build up. This can cause ketoacidosis—blood becomes too acidic—leading to vomiting, dehydration, fast breathing, sleepiness, and sometimes seizures. Illness, fasting, or eating too much protein can trigger attacks. The condition is inherited in an autosomal recessive way. Many children do well between attacks if they avoid triggers and follow an emergency plan during sickness. MedlinePlus+3MedlinePlus+3rarediseases.info.nih.gov+3

Other names

People and articles may use different names for the same disorder:

• Beta-ketothiolase deficiency (BKT deficiency)

• ACAT1 deficiency (from the gene name)

• Mitochondrial acetoacetyl-CoA thiolase deficiency

• T2 deficiency (T2 is the “thiolase 2” enzyme)

• Alpha-methyl-acetoacetyl-CoA thiolase (MAT) deficiency
  All of these refer to the same condition affecting ketone use and isoleucine breakdown. Orpha+1

Types

Doctors sometimes group patients by how and when the illness shows:

1. Infant- or toddler-onset with intermittent crises. This is most common. A healthy baby develops episodes of vomiting and deep breathing during fever or fasting. Between crises, many children are well. MedlinePlus

2. Neonatal or early-severe presentation. Rarely, symptoms start in the first weeks of life and can be severe. Orpha

3. Later-onset or milder course. Some people present later in childhood or even adulthood with fewer or milder crises. BioMed Central

4. Asymptomatic biochemical diagnosis. Identified on newborn screening or family testing without symptoms yet; still needs care plans to prevent crises. newbornscreening.hrsa.gov

Causes

Root cause

1. Biallelic pathogenic variants in the ACAT1 gene (autosomal recessive). You inherit one non-working copy from each parent. This reduces or blocks the thiolase enzyme in mitochondria. MedlinePlus+1

Common triggers that precipitate metabolic crises (the disease is genetic; these do not “cause” the disease but bring on attacks):

2. Fasting or long gaps between meals. Low glucose pushes the body to use fats and ketones; the defect then causes acid buildup. rarediseases.info.nih.gov

3. Fever and infections (cold, flu, stomach bugs) that increase energy needs. rarediseases.info.nih.gov

4. Vomiting or diarrhea leading to dehydration and poor intake. rarediseases.info.nih.gov

5. Physical stress or surgery without enough glucose supply. Orpha

6. High-fat, very low-carb diets that raise ketone production. Orpha

7. Prolonged heavy exercise without proper fueling (older children/adults). BioMed Central

8. Poor access to fluids during illness. rarediseases.info.nih.gov

9. Delayed treatment of a minor illness, allowing acidosis to build. rarediseases.info.nih.gov

10. Isoleucine overload from unusually high protein intake during illness (less common, but pathway-related). Orpha

11. Non-adherence to sick-day plans (missing extra carbs/fluids). newbornscreening.hrsa.gov

12. Intercurrent metabolic stress such as fasting for procedures. Orpha

13. Dehydrating climates/heat waves without added fluids. rarediseases.info.nih.gov

14. Missed newborn-screen follow-up (if identified) delaying education. newbornscreening.hrsa.gov

15. Untreated carnitine deficiency, which can reduce buffering of organic acids (supportive factor in some organic acidemias). Orpha

16. Certain catabolic medications (e.g., prolonged high-dose steroids) pushing the body into breakdown states. (General principle in organic acidemias.) Orpha

17. Intercurrent ketosis from fasting religious observance without medical planning. Orpha

18. Poor understanding of emergency letters by care teams, delaying dextrose. newbornscreening.hrsa.gov

19. Undiagnosed siblings (genetically affected) exposed to the same triggers. newbornscreening.hrsa.gov

20. Lack of ready carbohydrate sources at home during early illness. newbornscreening.hrsa.gov

Symptoms

1. Vomiting that may be persistent. rarediseases.info.nih.gov

2. Dehydration (dry mouth, no tears, less urine). rarediseases.info.nih.gov

3. Deep, rapid “Kussmaul” breathing from acidosis. rarediseases.info.nih.gov

4. Lethargy or unusual sleepiness. rarediseases.info.nih.gov

5. Irritability or behavior change. rarediseases.info.nih.gov

6. Poor feeding in infants. MedlinePlus

7. Fever from a trigger infection. rarediseases.info.nih.gov

8. Seizures in severe acidosis. rarediseases.info.nih.gov

9. Hypoglycemia or normal glucose with severe ketoacidosis (both reported). Orpha

10. Headache (older children) during ketotic crisis. rarediseases.info.nih.gov

11. Rapid heart rate from dehydration or acidosis. rarediseases.info.nih.gov

12. Breath that smells fruity (ketones). rarediseases.info.nih.gov

13. Confusion or coma in very severe cases. rarediseases.info.nih.gov

14. Developmental regression after severe crisis (some cases). PubMed

15. Muscle weakness or low tone during illness. Orpha

Diagnostic tests

Physical examination (what clinicians look for)

1. Vital signs and general appearance. Doctors check fever, heart rate, breathing rate, and blood pressure. A fast heart and deep breathing suggest acidosis or dehydration. This helps judge crisis severity and need for fluids and dextrose. rarediseases.info.nih.gov

2. Hydration status. Dry lips, no tears, sunken eyes, and poor skin turgor mean dehydration, which makes acidosis worse and needs prompt IV fluids. rarediseases.info.nih.gov

3. Respiratory pattern. Deep, rapid breathing (Kussmaul) is a classic clue to high acid levels. Clinicians also listen for wheeze or crackles to rule out lung infection as a trigger. rarediseases.info.nih.gov

4. Neurologic exam. Level of alertness, pupils, reflexes, and seizure activity are checked to detect encephalopathy from severe ketoacidosis. rarediseases.info.nih.gov

5. Abdominal and liver exam. The doctor may feel for an enlarged liver (hepatomegaly) or tenderness. This helps rule out other causes and document stress effects on the liver. Orpha

Manual / bedside tests

6. Capillary glucose (finger-stick). Fast, simple check for low, normal, or high glucose during a crisis. In BKT deficiency, glucose can be low or normal, but ketones are usually high. Orpha

7. Bedside blood gas (venous or arterial). Shows the pH and bicarbonate level. A low pH and low bicarbonate confirm metabolic acidosis and its severity. Orpha

8. Urine ketone dipstick. A quick test to confirm ketosis. Strong positives support a ketotic crisis and speed treatment decisions. newbornscreening.hrsa.gov

9. Point-of-care electrolytes. Sodium, potassium, chloride, and anion gap guide fluid and bicarbonate therapy and help detect dangerous imbalances. Orpha

Laboratory and pathological tests

10. Comprehensive metabolic panel and anion gap. Confirms high-anion-gap metabolic acidosis and checks kidney and liver function during crisis. Orpha

11. Serum β-hydroxybutyrate. Direct measure of ketones. High levels support ketotic acidosis. Orpha

12. Plasma ammonia and lactate. These help rule in/out other metabolic diseases and assess severity of decompensation. Ammonia may be normal or slightly high; marked hyperammonemia suggests another disorder. Orpha

13. Urine organic acids by GC-MS (key test). Shows characteristic elevation of 2-methyl-3-hydroxybutyrate, 2-methylacetoacetate, and tiglylglycine. This pattern points strongly to BKT deficiency. Wiley Online Library+2PubMed+2

14. Acylcarnitine profile (tandem MS). Often shows elevations consistent with isoleucine pathway block, such as C5-OH (2-methyl-3-hydroxybutyrylcarnitine) and sometimes C5:1 (tiglylcarnitine). This supports screening and crisis evaluation. newbornscreening.hrsa.gov

15. Plasma amino acids. Helps evaluate isoleucine metabolism and exclude other aminoacidopathies; supportive rather than diagnostic alone. Orpha

16. Carnitine (free and total). Some patients have low free carnitine during illness because it binds accumulating organic acids; replacement can be considered. Orpha

17. Enzyme assay (fibroblasts or lymphocytes). Measures mitochondrial acetoacetyl-CoA thiolase activity; reduced activity confirms the biochemical diagnosis. Orpha

18. Molecular genetic testing of the ACAT1 gene. Identifies the exact variants; more than 100 pathogenic variants have been reported. This confirms diagnosis and allows family testing. MedlinePlus+1

Electrodiagnostic tests

19. Electroencephalogram (EEG), when seizures or encephalopathy occur. EEG documents seizure activity and helps guide anti-seizure treatment during acute decompensation. It does not diagnose BKT deficiency but supports crisis care. PubMed

20. Electrocardiogram (ECG) in severe dehydration or electrolyte imbalance. Checks heart rhythm effects of acidosis, potassium shifts, or bicarbonate therapy; it is supportive care, not a primary diagnostic test. Orpha

Imaging tests

21. Brain MRI (during or after a severe crisis). Some patients show reversible changes, sometimes in the basal ganglia or white matter, sometimes called “metabolic stroke.” Imaging helps assess injury and recovery. PubMed

22. Head CT (if MRI not available in emergencies). Faster but less detailed; used to exclude bleeding or major structural problems in obtunded patients. Orpha

23. Abdominal ultrasound (selected cases). Looks for liver enlargement or other causes of vomiting; supportive, not specific. Orpha

24. Chest X-ray (if respiratory symptoms). Helps find pneumonia as a trigger for decompensation. Orpha

25. Echocardiogram (rare, case-by-case). Considered if severe acidosis and electrolyte shifts raise concern for cardiac function; not a routine test. Orpha

Non-pharmacological treatments (therapies & others)

1. Sick-day high-glucose plan
   Description: During fevers, vomiting, or poor intake, start a written plan that increases glucose (sugar) intake early—using oral glucose solutions or IV dextrose if needed—to prevent ketone build-up. Parents keep oral rehydration or glucose drinks at home and seek care early.
   Purpose: Prevent or blunt ketoacidosis during illness.
   Mechanism: Extra glucose supplies ready energy, so the body does not switch to fat breakdown and heavy isoleucine catabolism, both of which raise ketones and organic acids. Pediatrics Publications+1

2. Avoid prolonged fasting
   Description: Keep regular meals and snacks; shorten overnight fasting in infants and toddlers; use bedtime carbohydrate if needed.
   Purpose: Reduce metabolic stress and ketone production.
   Mechanism: Frequent carbs keep insulin up and fat breakdown down, lowering acid load. Metabolic Support UK+1

3. Prompt treatment of infections
   Description: Treat fevers and infections quickly; maintain fluids and calories.
   Purpose: Illness increases energy demand and raises ketones; fast treatment lowers risk of crisis.
   Mechanism: Reduces catabolic hormones and stress that drive ketogenesis. MedlinePlus

4. Moderate protein intake (avoid very high protein loads)
   Description: Provide age-appropriate protein; avoid big protein boluses.
   Purpose: Limits isoleucine influx that can worsen metabolite build-up.
   Mechanism: Reduces substrate entering the blocked isoleucine pathway. Orpha

5. Education of caregivers & emergency letter
   Description: Families carry a one-page emergency protocol to the ER.
   Purpose: Speeds correct treatment in any hospital.
   Mechanism: Standardizes early glucose, fluids, acid-base checks, and monitoring. metab.ern-net.eu

6. Home ketone monitoring during illness
   Description: Use urine ketone sticks when sick.
   Purpose: Early detection of rising ketones.
   Mechanism: Guides faster escalation to high-carb intake or hospital IV dextrose. Pediatrics Publications

7. Hydration and electrolyte balance
   Description: Encourage fluids; use oral rehydration solutions if vomiting.
   Purpose: Prevent dehydration that concentrates acids.
   Mechanism: Dilutes and helps excrete organic acids; supports circulation. filiere-g2m.fr

8. Nutritionist-designed meal pattern
   Description: Work with a metabolic dietitian on age-appropriate calories, carbs, and protein.
   Purpose: Keep steady fuel to prevent catabolism.
   Mechanism: Stable insulin and glucose suppress ketogenesis and isoleucine flux. MedlinePlus

9. Hospital IV glucose early in decompensation
   Description: At first signs of metabolic crisis, start high-rate IV dextrose per protocol.
   Purpose: Reverse ketosis fast and protect the brain.
   Mechanism: Glucose raises insulin and turns off fat/ketone production. PMC

10. Careful correction of acidosis
    Description: Treat severe metabolic acidosis with bicarbonate as needed, guided by pH and bicarbonate levels.
    Purpose: Restore pH to safer range.
    Mechanism: Bicarbonate buffers acid; used judiciously to avoid complications. PMC

11. ICU monitoring in severe crises
    Description: Use continuous cardiorespiratory and lab monitoring.
    Purpose: Detect rapid shifts in glucose, potassium, and acid-base status.
    Mechanism: Tight control prevents arrhythmias, cerebral edema, and shock. PMC

12. Developmental follow-up & early intervention
    Description: Screen for speech/motor delays post-crisis; start therapies as needed.
    Purpose: Optimize long-term outcomes.
    Mechanism: Early rehab supports neurodevelopment after metabolic stress. BioMed Central

13. Vaccinations on time
    Description: Keep routine immunizations current.
    Purpose: Reduce infection-triggered decompensation.
    Mechanism: Prevents febrile illnesses that raise ketones. metab.ern-net.eu

14. Temperature and pain control when sick
    Description: Use antipyretics and comfort care.
    Purpose: Reduce metabolic demand from fever and stress.
    Mechanism: Lower catecholamines and cortisol, which otherwise drive ketogenesis. Pediatrics Publications

15. School and caregiver plans
    Description: Provide written feeding and sick-day steps to schools/daycare.
    Purpose: Ensure timely carbs and early recognition of symptoms.
    Mechanism: Prevents long gaps without calories. Pediatrics Publications

16. Genetic counseling for family
    Description: Explain inheritance, carrier testing, and future pregnancy options.
    Purpose: Support family planning and newborn screening readiness.
    Mechanism: Informs risk of autosomal recessive conditions. rarediseases.info.nih.gov

17. Newborn screening follow-through
    Description: If screen positive, confirm with metabolic and genetic testing and start preventive care early.
    Purpose: Avoid first crisis.
    Mechanism: Early diagnosis enables diet/illness plans before decompensation. Newborn Screening

18. Regular metabolic clinic visits
    Description: Review growth, diet, labs, and emergency preparedness.
    Purpose: Maintain stability and catch issues early.
    Mechanism: Ongoing surveillance of acid-base status and nutrition. BioMed Central

19. Careful introduction of new diets (e.g., avoid “keto” diets)
    Description: Do not use high-fat ketogenic diets.
    Purpose: Prevent excessive ketone production.
    Mechanism: Avoids pushing metabolism toward ketogenesis. MedlinePlus

20. Medical ID bracelet/card
    Description: The child carries a diagnosis card with emergency steps.
    Purpose: Speeds correct care in emergencies.
    Mechanism: Triggers early glucose and monitoring at triage. metab.ern-net.eu

Drug treatments

Important: There is no FDA-approved curative drug for ACAT1 deficiency. Medicines below are standard supportive agents for ketoacidosis, dehydration, nausea, infections, and related issues during an episode—chosen and dosed by clinicians based on weight, labs, and severity. PMC+1

1. Dextrose Injection (IV glucose)
   Class: Carbohydrate solution (parenteral nutrition/IV fluid).
   Typical use & timing: Immediate in the ER/ICU at high glucose infusion rates during decompensation; titrated to suppress ketogenesis.
   Purpose/Mechanism: Supplies quick energy, raises insulin, and shuts down fat and ketone production.
   Dose examples (clinician-directed): Vary by age/weight and concentration (e.g., D10–D20%), with frequent glucose checks; insulin may be co-administered if hyperglycemia develops.
   Key adverse effects: Hyperglycemia, fluid/electrolyte shifts; monitor closely. FDA Access Data+2FDA Access Data+2

2. Insulin (Regular insulin, IV/SC)
   Class: Short-acting human insulin.
   Timing: During high-rate dextrose infusion if blood glucose runs high, or to reduce ketosis under specialist guidance.
   Purpose/Mechanism: Enhances cellular glucose uptake, strongly inhibits lipolysis/ketogenesis.
   Dose examples: IV infusion protocols or SC doses per ICU pathways; careful potassium monitoring.
   Key adverse effects: Hypoglycemia, hypokalemia; needs continuous monitoring. FDA Access Data+1

3. Sodium Bicarbonate (IV)
   Class: Systemic alkalinizing agent.
   Timing: For severe metabolic acidosis when pH and bicarbonate are critically low and not improving with first-line measures.
   Purpose/Mechanism: Buffers excess hydrogen ions; raises serum bicarbonate and pH.
   Dose examples: Bolus or infusion per blood gas; cautious use to avoid hypernatremia/CO₂ load.
   Key adverse effects: Sodium/fluid overload, paradoxical CNS acidosis if misused; specialist oversight required. DailyMed+1

4. Levocarnitine (CARNITOR®)
   Class: Carnitine supplement (metabolic cofactor).
   Timing: Chronically in some patients with secondary carnitine depletion; acute IV/PO use may be considered by specialists.
   Purpose/Mechanism: Restores carnitine pools to shuttle fatty acyl groups; helps conjugate and excrete toxic acyl compounds.
   Dose examples: Per label for inborn errors with secondary carnitine deficiency; individualized.
   Key adverse effects: GI upset; rare seizures at high doses. FDA Access Data+2FDA Access Data+2

5. Potassium (acetate or chloride) supplements (IV/PO)
   Class: Electrolyte.
   Timing: When insulin therapy and urinary losses lower serum potassium.
   Purpose/Mechanism: Maintains cardiac and neuromuscular stability.
   Dose examples: ICU protocols with continuous ECG and labs.
   Key adverse effects: Arrhythmias if misdosed. PMC

6. Phosphate replacement (IV/PO)
   Class: Electrolyte.
   Timing: If hypophosphatemia occurs during recovery.
   Purpose/Mechanism: Restores ATP and red cell/respiratory muscle function.
   Dose examples: Based on serum levels; careful monitoring. PMC

7. Thiamine (Vitamin B1, IV/PO)
   Class: Water-soluble vitamin.
   Timing: Considered during dextrose therapy in malnourished patients.
   Purpose/Mechanism: Cofactor in carbohydrate metabolism.
   Safety: Generally safe at standard doses. (General metabolic care practice; not disease-specific.) Pediatrics Publications

8. Ondansetron (antiemetic)
   Class: 5-HT3 antagonist.
   Timing: Nausea/vomiting during attacks to maintain oral intake.
   Purpose/Mechanism: Blocks serotonin receptors in the gut/brain.
   Dose examples: Weight-based pediatric dosing.
   Key adverse effects: Constipation, QT prolongation caution. (FDA-labeled antiemetic; supportive use.) filiere-g2m.fr

9. Acetaminophen (antipyretic/analgesic)
   Class: Analgesic/antipyretic.
   Purpose/Mechanism: Lowers fever and pain to reduce metabolic stress.
   Safety: Use weight-based dosing; avoid overdosing. (Standard pediatric labeling.) Pediatrics Publications

10. Ibuprofen (antipyretic/NSAID)
    Class: NSAID.
    Purpose/Mechanism: Fever control; reduces inflammatory stress.
    Cautions: Hydration; avoid with renal impairment. (FDA-labeled.) Pediatrics Publications

11. Oral rehydration salts
    Class: Balanced electrolyte/glucose solution.
    Purpose/Mechanism: Supports hydration and glucose at home in mild illness.
    Use: Follow pediatric ORS instructions. filiere-g2m.fr

12. Antibiotics (e.g., amoxicillin) when bacterial infection is confirmed/suspected
    Class: Beta-lactam antibiotic.
    Purpose/Mechanism: Treats infection triggers.
    Cautions: Only when indicated by a clinician. (FDA-labeled antibiotics; choice depends on site/resistance.) metab.ern-net.eu

13. Proton-pump inhibitor short course if severe gastritis/erosions with vomiting
    Class: PPI.
    Purpose/Mechanism: Reduces gastric acid; protects mucosa during severe illness.
    Cautions: Short-term; review drug interactions. (FDA-labeled PPIs.) FDA Access Data

14. Heparin lock flushes / IV line care solutions
    Class: Device/line maintenance.
    Purpose/Mechanism: Maintains IV access safely during crises.
    Cautions: Protocol-driven. metab.ern-net.eu

15. Glucose gel (buccal) for mild hypoglycemia
    Class: Oral glucose.
    Purpose/Mechanism: Rapid glucose to stop ketogenesis in mild cases if patient is alert.
    Use: Per pediatric guidance. Pediatrics Publications

16. Multivitamin with minerals (age-appropriate)
    Class: Micronutrient support.
    Purpose/Mechanism: Supports general metabolism during recovery.
    Cautions: Avoid megadoses without indication. Pediatrics Publications

17. Probiotics (supportive)
    Class: Live microbes.
    Purpose/Mechanism: May help GI tolerance during recovery; evidence modest.
    Cautions: Avoid in severe immunocompromise. Pediatrics Publications

18. Trace elements (zinc if deficient)
    Class: Micronutrient.
    Purpose/Mechanism: Supports healing and appetite.
    Cautions: Only if deficiency suspected/confirmed. Pediatrics Publications

19. Anticonvulsants if seizures occur (e.g., levetiracetam)
    Class: Antiepileptic.
    Purpose/Mechanism: Controls seizures during severe acidosis.
    Cautions: Specialist-led choice/dosing. BioMed Central

20. Sedation/antiemetic combinations (specialist-directed)
    Class: Symptom control.
    Purpose/Mechanism: Enables safe hydration and monitoring in ICU.
    Cautions: Airway and cardiorespiratory monitoring. PMC

Dietary molecular supplements

1. Levocarnitine (if not given as a prescription drug)
   Description: Supports removal of acyl groups and may replenish low carnitine stores seen in some inborn errors; improves energy transport into mitochondria.
   Dose: Only as prescribed; label-based dosing varies by age/weight.
   Function/Mechanism: Conjugates toxic acyls and aids fatty-acid transport. FDA Access Data

2. Glucose polymers (maltodextrin) for sick-day carbs
   Description: Easily digested carbohydrate powders for drinks.
   Dose: As directed by dietitian in sick-day plans.
   Function/Mechanism: Provides rapid glucose to suppress ketones. Pediatrics Publications

3. Oral rehydration solution (ready-made)
   Description: Balanced glucose-electrolyte drink.
   Dose: Per label/weight.
   Function/Mechanism: Hydrates and provides glucose to limit ketosis. filiere-g2m.fr

4. Age-appropriate multivitamin
   Description: Covers potential micronutrient gaps during recovery.
   Dose: As per product/age.
   Mechanism: Supports enzyme systems broadly. Pediatrics Publications

5. Riboflavin (B2)
   Description: General mitochondrial cofactor; routine benefit in ACAT1 deficiency is not established, but adequate B-vitamin status is reasonable.
   Dose: Age-appropriate RDA unless prescribed.
   Mechanism: Supports redox/energy pathways. Pediatrics Publications

6. Thiamine (B1)
   Description: Helps carbohydrate metabolism during high-glucose therapy, especially if intake has been poor.
   Dose: Age-appropriate RDA or clinician-directed.
   Mechanism: Cofactor for pyruvate dehydrogenase. Pediatrics Publications

7. Vitamin D
   Description: Supports bone and immune health during chronic illness.
   Dose: As per pediatric guidance and serum levels.
   Mechanism: Hormone-like effects on bone/immune function. Pediatrics Publications

8. Omega-3 fatty acids
   Description: Gentle anti-inflammatory support; not to be used to raise dietary fat as a “keto diet.”
   Dose: Age-guided amounts.
   Mechanism: Modulates inflammatory mediators; no direct effect on ketones. Pediatrics Publications

9. Zinc (if deficient)
   Description: Supports appetite, wound healing, and immunity.
   Dose: Only if indicated.
   Mechanism: Enzyme cofactor across many pathways. Pediatrics Publications

10. Folate/B12 (if low)
    Description: Correct deficiencies that can follow poor intake during illness.
    Dose: Lab-guided.
    Mechanism: DNA synthesis and red-cell production. Pediatrics Publications

Immunity booster / regenerative / stem-cell drugs

There are currently no approved stem-cell or “regenerative” drugs that treat ACAT1 deficiency or safely “boost immunity” for this condition. The safest, evidence-based approach is vaccination, nutrition, prompt infection control, and specialist-led supportive care. Any product sold as a stem-cell or “immune booster” drug for this disease should be avoided unless part of a regulated clinical trial. BioMed Central+1

(Instead, clinicians may prescribe the supportive items above—vaccines on schedule, levocarnitine if indicated, and aggressive sick-day glucose/fluids—to prevent crises.) FDA Access Data+1

Surgeries / procedures (what they are, why done)

1. IV line placement (peripheral or central)
   What: Inserted in ER/ICU.
   Why: To deliver high-rate dextrose, electrolytes, insulin, and bicarbonate quickly during crises. PMC

2. Endotracheal intubation (if severe)
   What: Breathing tube with ventilator.
   Why: For severe acidosis or altered mental status to control ventilation and oxygenation while correcting chemistry. PMC

3. Temporary dialysis/hemofiltration (rare)
   What: Blood purification in ICU.
   Why: Considered in extreme metabolic acidosis or hyperammonemia unresponsive to medical therapy, per specialist guidance. PMC

4. Feeding tube (NG or gastrostomy) (select cases)
   What: Tube feeding support.
   Why: To ensure steady carbohydrate delivery and prevent fasting in children with recurrent poor oral intake. Pediatrics Publications

5. Lumbar puncture / neuroimaging (diagnostic procedures)
   What: Tests, not treatments.
   Why: To evaluate encephalopathy/seizures during severe attacks and rule out other causes. PMC

Note: Liver transplant is not standard for ACAT1 deficiency and is not proven to correct the systemic enzyme defect; most patients do well with conservative care when managed early. Orpha

Preventions

1. Keep a written sick-day plan accessible at home and school. metab.ern-net.eu

2. Avoid fasting; use bedtime carbs in toddlers/young children. Metabolic Support UK

3. Treat infections early; maintain hydration and calories. MedlinePlus

4. Carry an emergency letter (diagnosis + ER orders). metab.ern-net.eu

5. Up-to-date vaccines for the child and household. metab.ern-net.eu

6. Regular clinic follow-up with a metabolic team. BioMed Central

7. School/daycare training on snacks, signs, and steps. Pediatrics Publications

8. Avoid high-protein binges; keep balanced meals. Orpha

9. No ketogenic dieting. MedlinePlus

10. Home ketone checks during illness; escalate early. Pediatrics Publications

When to see doctors (red flags)

Seek urgent medical care immediately for vomiting that prevents fluids, fast or deep breathing, unusual sleepiness, confusion, seizures, or any illness with poor intake for more than a few hours. These signs may mean rising ketones and acid levels that can worsen quickly; early IV glucose, fluids, and monitoring prevent complications. Follow your emergency letter and go to the nearest ER, asking staff to contact your child’s metabolic specialist. PMC+1

What to eat and what to avoid

Eat (everyday pattern):

1. Regular carbohydrate-rich meals and snacks (rice, bread, pasta, fruits, milk/yogurt if tolerated).
2. Fluids often, especially during hot weather or minor illness.
3. Balanced protein in age-appropriate portions; distribute across meals.
4. Sick-day drinks with glucose (per plan) at the first sign of illness. Pediatrics Publications+1

Avoid / limit:

1. Prolonged fasting or skipping meals.
2. Ketogenic or very high-fat diets.
3. Large protein loads at one sitting.
4. Unsupervised supplements promising “detox,” “immune boost,” or “stem-cell” effects.
5. Dehydration during illness—act early with your plan. MedlinePlus+1

Frequently Asked Questions

1. Is there a cure?
   No. Treatment focuses on preventing and treating ketoacidosis with sick-day glucose, early IV dextrose, fluids, and careful acid-base management. Many children do well with good plans. PMC+1

2. What causes it?
   Harmful changes in ACAT1 reduce a mitochondrial enzyme that handles isoleucine and ketone metabolism. MedlinePlus

3. How is it inherited?
   Autosomal recessive—both parents are usually carriers. rarediseases.info.nih.gov

4. When do symptoms start?
   Often between 6–24 months with episodes of ketoacidosis, often during illness or fasting. MedlinePlus

5. What triggers a crisis?
   Illness, fasting, dehydration, or unusually high protein intake. MedlinePlus

6. What is an emergency letter?
   A one-page note for ER teams with steps: rapid IV dextrose, labs, electrolytes, and monitoring. metab.ern-net.eu

7. Is carnitine helpful?
   Clinicians sometimes use levocarnitine when there’s secondary deficiency; it can help remove toxic acyl groups, but it’s not a cure and must be prescribed. FDA Access Data

8. Is bicarbonate always used?
   No. It’s for severe acidosis not improving with first-line measures, and it requires careful monitoring. PMC

9. Can my child live a normal life?
   Many have favorable outcomes with prevention and quick treatment of crises; regular follow-up is important. BioMed Central

10. Are “keto” diets safe here?
    No. They generate ketones and can be dangerous for this condition. MedlinePlus

11. What about newborn screening?
    Some programs can detect it early; confirm with metabolic testing and genetics. Newborn Screening

12. Do we need genetic counseling?
    Yes—helps with carrier testing and future pregnancy planning. rarediseases.info.nih.gov

13. Are stem-cell or regenerative drugs available?
    No approved options; avoid unproven products. BioMed Central

14. Why is insulin sometimes given if my child isn’t diabetic?
    To control glucose during high-rate dextrose infusions and shut down ketone production safely. FDA Access Data

15. Which departments should follow my child?
    A metabolic genetics team with a metabolic dietitian, plus primary care for vaccines and infection prevention. BioMed Central

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 23, 2025.

Previous

Alpha-Methylacetoacetic Aciduria

Next

Alpha-Methylacetoacetic Aciduria

Related Articles

Added to wishlistRemoved from wishlist 0

Congenital Epstein–Barr Virus Infection

Added to wishlistRemoved from wishlist 0

Mother-to-Child Transmission of Enterovirus Infection

Added to wishlistRemoved from wishlist 0

Congenital Enterovirus Infectious Disease

Added to wishlistRemoved from wishlist 0

Congenital Enterovirus Infection